• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性呼吸衰竭的肌萎缩侧索硬化症患者呼吸困难的多维性:气促感、焦虑和恐惧。

The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear.

机构信息

Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, F-75005, Paris, France; AP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie et Réanimation Médicale du Département R3S, F-75013, Paris, France.

CHU Lille, Clinique des Maladies Respiratoires, F-59000 Lille, Inserm U1019, CNRS UMR 8204, Center for Infection and Immunity of Lille, Institut Pasteur de Lille, F 59000, Lille, France.

出版信息

Respir Med. 2018 Dec;145:1-7. doi: 10.1016/j.rmed.2018.10.010. Epub 2018 Oct 17.

DOI:10.1016/j.rmed.2018.10.010
PMID:30509697
Abstract

BACKGROUND

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder leading to chronic respiratory failure. Few studies have investigated ALS-related dyspnoea, and none have characterised the emotional distress it inflicts. We hypothesised that ALS-related dyspnoea has a strong affective component that relates to quality of life.

METHODS

This prospective, observational study was conducted in 41 ALS patients >18 with chronic respiratory failure and an indication for noninvasive ventilation (NIV). Dyspnoea was assessed using the Multidimensional Dyspnea Profile (MDP) at baseline and 1 month after NIV initiation. Correlations between scores evaluating the sensory and affective dimensions of dyspnoea and other patient-reported outcomes and pulmonary function tests were analysed.

RESULTS

Dyspnoea was described as intense (median [IQR] score on a 0-10 scale: 6.5 [4.0-7.5]). The sensory dimension of dyspnoea was polymorphic, but «air hunger» was the most common (48.8%) and the most intense (6 [4-8]) sensory descriptor. In the affective domain, most patients rated «anxious» (85.4%) and «afraid» (60.9%) above 0. The MDP affective dimension correlated significantly with other patient-reported outcomes, with the strongest correlation being between MDP «anxious» and the anxiety component of the Hospital Anxiety Depression Scale (Pearson's R = 0.70). One month after initiation of NIV, dyspnoea during unassisted breathing was described in virtually the same terms, particularly the affective dimension.

DISCUSSION

ALS-related dyspnoea is intense and fear-provoking, persists during unassisted breathing between NIV sessions, and significantly impacts health-related quality of life. This study highlights the need for increased awareness of and research into ALS-related dyspnoea.

摘要

背景

肌萎缩侧索硬化症(ALS)是一种导致慢性呼吸衰竭的神经退行性疾病。很少有研究调查与 ALS 相关的呼吸困难,也没有研究描述其引发的情绪困扰。我们假设与 ALS 相关的呼吸困难具有强烈的情感成分,与生活质量有关。

方法

这项前瞻性、观察性研究纳入了 41 名年龄>18 岁且患有慢性呼吸衰竭并需要无创通气(NIV)的 ALS 患者。在基线和开始 NIV 后 1 个月使用多维呼吸困难量表(MDP)评估呼吸困难。分析评估呼吸困难感觉和情感维度的评分与其他患者报告的结局和肺功能测试之间的相关性。

结果

呼吸困难被描述为强烈(0-10 分制的中位数[IQR]评分:6.5 [4.0-7.5])。呼吸困难的感觉维度呈多态性,但“空气饥饿”是最常见的(48.8%)和最强烈的(6 [4-8])感觉描述符。在情感领域,大多数患者将“焦虑”(85.4%)和“恐惧”(60.9%)评为>0。MDP 情感维度与其他患者报告的结局显著相关,与医院焦虑抑郁量表(HADS)的焦虑成分之间的相关性最强(Pearson's R=0.70)。开始 NIV 后 1 个月,在无辅助呼吸期间,呼吸困难的描述几乎相同,特别是情感维度。

讨论

与 ALS 相关的呼吸困难强烈且令人恐惧,在 NIV 治疗期间的无辅助呼吸之间持续存在,并且对健康相关的生活质量有显著影响。这项研究强调了需要提高对与 ALS 相关的呼吸困难的认识和研究。

相似文献

1
The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear.慢性呼吸衰竭的肌萎缩侧索硬化症患者呼吸困难的多维性:气促感、焦虑和恐惧。
Respir Med. 2018 Dec;145:1-7. doi: 10.1016/j.rmed.2018.10.010. Epub 2018 Oct 17.
2
Dyspnea in amyotrophic lateral sclerosis: The Dyspnea-ALS-Scale (DALS-15) essentially contributes to the diagnosis of respiratory impairment.肌萎缩侧索硬化症中的呼吸困难:呼吸困难-肌萎缩侧索硬化症量表(DALS-15)对呼吸功能损害的诊断具有重要意义。
Respir Med. 2019 Jul-Aug;154:116-121. doi: 10.1016/j.rmed.2019.06.014. Epub 2019 Jun 19.
3
The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea.呼吸困难-肌萎缩侧索硬化症量表(DALS-15)优化了呼吸困难的肌萎缩侧索硬化症(ALS)患者的个体治疗。
Health Qual Life Outcomes. 2019 Jun 3;17(1):95. doi: 10.1186/s12955-019-1167-0.
4
Cortical drive to breathe in amyotrophic lateral sclerosis: a dyspnoea-worsening defence?肌萎缩侧索硬化症中的皮质呼吸驱动:加重呼吸困难的防御机制?
Eur Respir J. 2016 Jun;47(6):1818-28. doi: 10.1183/13993003.01686-2015. Epub 2016 Apr 13.
5
Relieving dyspnoea by non-invasive ventilation decreases pain thresholds in amyotrophic lateral sclerosis.无创通气缓解呼吸困难可降低肌萎缩侧索硬化症患者的痛阈。
Thorax. 2017 Mar;72(3):230-235. doi: 10.1136/thoraxjnl-2016-208544. Epub 2016 Aug 9.
6
Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact: A prospective observational study.急性呼吸衰竭患者接受无创通气时的呼吸困难:患病率、危险因素和预后影响:一项前瞻性观察研究。
Eur Respir J. 2018 Aug 9;52(2). doi: 10.1183/13993003.02637-2017. Print 2018 Aug.
7
Predictors of need for noninvasive ventilation during respiratory tract infections in medically stable, non-ventilated subjects with amyotrophic lateral sclerosis.肌萎缩侧索硬化症病情稳定、无需通气的患者在呼吸道感染期间无创通气需求的预测因素
Respir Care. 2015 Apr;60(4):492-7. doi: 10.4187/respcare.03553. Epub 2014 Nov 18.
8
Is chronic ventilatory support really effective in patients with amyotrophic lateral sclerosis?慢性通气支持对肌萎缩侧索硬化症患者真的有效吗?
J Neurol. 2016 Dec;263(12):2456-2461. doi: 10.1007/s00415-016-8288-8. Epub 2016 Sep 16.
9
Variation in noninvasive ventilation use in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中非侵入性通气使用的差异。
Neurology. 2019 Jul 16;93(3):e306-e316. doi: 10.1212/WNL.0000000000007776. Epub 2019 Jun 10.
10
Tolerance of Volume Control Noninvasive Ventilation in Subjects With Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症患者对容量控制无创通气的耐受性
Respir Care. 2015 Dec;60(12):1765-71. doi: 10.4187/respcare.04172. Epub 2015 Sep 29.

引用本文的文献

1
Multimodal physiological correlates of dyspnea ratings during breath-holding in healthy humans.健康人屏气期间呼吸困难评分的多模态生理关联
Eur J Appl Physiol. 2025 Mar;125(3):729-737. doi: 10.1007/s00421-024-05627-8. Epub 2024 Oct 10.
2
Specialists in Chronic Respiratory Failure Should Serve More than Just Ventilator-Dependent Patients.慢性呼吸衰竭专家的服务对象不应仅限于依赖呼吸机的患者。
Ann Am Thorac Soc. 2024 Sep;21(9):1342-1343. doi: 10.1513/AnnalsATS.202404-359LE.
3
Optimizing breathlessness management in amyotrophic lateral sclerosis: insights from a comprehensive systematic review.
优化肌萎缩侧索硬化症呼吸困难的管理:来自综合系统评价的见解。
BMC Palliat Care. 2024 Apr 16;23(1):100. doi: 10.1186/s12904-024-01429-z.
4
Practical Guide to Management of Long-Term Noninvasive Ventilation for Adults With Chronic Neuromuscular Disease.成人慢性神经肌肉疾病长期无创通气管理实用指南。
Respir Care. 2023 Aug;68(8):1123-1157. doi: 10.4187/respcare.10349. Epub 2023 Mar 15.
5
Effects of Stress Psychological Intervention on the Cardiopulmonary Function, Negative Emotion, Self-Efficacy, and Quality of Life in Patients with Acute Respiratory Failure.应激心理干预对急性呼吸衰竭患者心肺功能、负性情绪、自我效能感及生活质量的影响
Evid Based Complement Alternat Med. 2021 Sep 13;2021:9359102. doi: 10.1155/2021/9359102. eCollection 2021.
6
Pathophysiology and Treatment of Non-motor Dysfunction in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化中非运动功能障碍的病理生理学和治疗。
CNS Drugs. 2021 May;35(5):483-505. doi: 10.1007/s40263-021-00820-1. Epub 2021 May 15.
7
Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.罕见肌肉骨骼和神经肌肉疾病的疼痛表型。
Neurosci Biobehav Rev. 2021 May;124:267-290. doi: 10.1016/j.neubiorev.2021.02.009. Epub 2021 Feb 10.
8
Air Hunger: A Primal Sensation and a Primary Element of Dyspnea.气促感:一种原始感觉和呼吸困难的主要元素。
Compr Physiol. 2021 Feb 12;11(2):1449-1483. doi: 10.1002/cphy.c200001.
9
The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea.呼吸困难-肌萎缩侧索硬化症量表(DALS-15)优化了呼吸困难的肌萎缩侧索硬化症(ALS)患者的个体治疗。
Health Qual Life Outcomes. 2019 Jun 3;17(1):95. doi: 10.1186/s12955-019-1167-0.